Literature DB >> 9384405

Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.

A Doğan1, A M Rao, M K Başkaya, V L Rao, J Rastl, D Donaldson, R J Dempsey.   

Abstract

Polyamines and N-methyl-D-aspartate (NMDA) receptors are both thought to play an important role in secondary neuronal injury after cerebral ischemia. Ifenprodil, known as a noncompetitive inhibitor of polyamine sites at the NMDA receptor, was studied after transient focal cerebral ischemia occurred. Spontaneously hypertensive male rats, each weighing between 250 and 350 g, underwent 3 hours of tandem middle cerebral artery (MCA) and common carotid artery occlusion followed by reperfusion for a period of 3 hours or 21 hours. Intravenous ifenprodil (10 microg/kg/minute) or saline infusion was started immediately after the onset of MCA occlusion and continued throughout the ischemic period. Physiological parameters including blood pressure, blood gas levels, blood glucose, hemoglobin, and rectal and temporal muscle temperatures were monitored. Six rats from each group were evaluated at 6 hours postocclusion for brain water content, an indicator of brain edema, and Evans blue dye extravasation for blood-brain barrier breakdown. Infarct volume was also measured in six rats from each group at 6 and 24 hours postocclusion. Ifenprodil treatment significantly reduced brain edema (82.5 +/- 0.4% vs. 83.5 +/- 0.4%, p < 0.05) and infarct volume (132 +/- 14 mm3 vs. 168 +/- 25 mm3, p < 0.05) compared with saline treatment, with no alterations in temporal muscle (brain) or rectal (body) temperature (35.9 +/- 0.4 degrees C vs. 36.2 +/- 0.2 degrees C; 37.7 +/- 0.4 degrees C vs. 37.6 +/- 0.6 degrees C; not significant). These results demonstrate that ifenprodil has neuroprotective properties after ischemia/reperfusion injury in the absence of hypothermia. This indicates that antagonists selective for the polyamine site of the NMDA receptors may be a viable treatment option and helps to explain some of the pathophysiological mechanisms involved in secondary injury after transient focal cerebral ischemia has occurred.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9384405     DOI: 10.3171/jns.1997.87.6.0921

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Hydrogen-rich saline is cerebroprotective in a rat model of deep hypothermic circulatory arrest.

Authors:  Li Shen; Jun Wang; Kun Liu; Chunzhang Wang; Changtian Wang; Haiwei Wu; Qiang Sun; Xuejun Sun; Hua Jing
Journal:  Neurochem Res       Date:  2011-04-22       Impact factor: 3.996

2.  Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.

Authors:  Yesim A Tahirovic; Matthew Geballe; Ewa Gruszecka-Kowalik; Scott J Myers; Polina Lyuboslavsky; Phuong Le; Adam French; Hasan Irier; Woo-Baeg Choi; Keith Easterling; Hongjie Yuan; Lawrence J Wilson; Robert Kotloski; James O McNamara; Raymond Dingledine; Dennis C Liotta; Stephen F Traynelis; James P Snyder
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

3.  Behavioral deficits and cellular damage following developmental ethanol exposure in rats are attenuated by CP-101,606, an NMDAR antagonist with unique NR2B specificity.

Authors:  B Lewis; K A Wellmann; A M H Kehrberg; M L Carter; T Baldwin; M Cohen; S Barron
Journal:  Pharmacol Biochem Behav       Date:  2011-10-20       Impact factor: 3.533

4.  Traumatic Brain Injury-Induced Neuronal Apoptosis is Reduced Through Modulation of PI3K and Autophagy Pathways in Mouse by FTY720.

Authors:  Li Zhang; Ke Ding; Handong Wang; Yong Wu; Jianguo Xu
Journal:  Cell Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.046

5.  Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonists.

Authors:  Jitendra R Dave; Anthony J Williams; John R Moffett; Michael L Koenig; Frank C Tortella
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

6.  A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.

Authors:  Weiwei Yen; John Williamson; Edward H Bertram; Jaideep Kapur
Journal:  Epilepsy Res       Date:  2004-03       Impact factor: 3.045

7.  Conantokin-G attenuates detrimental effects of NMDAR hyperactivity in an ischemic rat model of stroke.

Authors:  Rashna Balsara; Alexander Dang; Deborah L Donahue; Tiffany Snow; Francis J Castellino
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

8.  Fucoxanthin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways.

Authors:  Li Zhang; Handong Wang; Youwu Fan; Yongyue Gao; Xiang Li; Zhigang Hu; Ke Ding; Yujie Wang; Xiaoliang Wang
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

9.  A microsurgical procedure for middle cerebral artery occlusion by intraluminal monofilament insertion technique in the rat: a special emphasis on the methodology.

Authors:  Aslan Güzel; Roland Rölz; Guido Nikkhah; Ulf D Kahlert; Jaroslaw Maciaczyk
Journal:  Exp Transl Stroke Med       Date:  2014-06-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.